Angiogenesis
Progen Presents Preclinical Data for Second-Generation Anti-Tumor Compounds at AACR-NCI-EORTC International Conference
Published in Medical Patent Law Weekly, November 7th, 2007
Dr. Keith Dredge, Progen's Preclinical Development Manager, is presenting the data in a poster entitled, "Heparan Sulfate Mimetics-Potent Angiogenesis Inhibitors for Cancer Therapeutics" at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, in San Francisco.
These studies evaluated the compounds' ability to inhibit new blood vessel formation in several in vitro models of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Acidosis
Recent findings from Cleveland Clinic highlight research in acidosis - Arthritis
Can-Fite to Conduct a Confirmatory Phase IIb Trial in Early 2008 as Part of Ongoing Development of CF101 for the Treatment of Rheumatoid Arthritis - Bioengineering
IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities - Bioengineering
X-spine Systems, Inc. Granted Key Patent for Disk Augmentation System - Biomedicine
BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants - Biomedicine
California Healthcare Institute Joins with Coalition to Ensure Patent Reform Does Not Undermine Biotech Innovation - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
